Remove Angina Remove Heart Transplant Remove Tricuspid
article thumbnail

Abstract 4144084: Enhanced External Counterpulsation as a Novel Treatment for Heart Transplant Candidates with Ischemic Heart Failure with Reduced Ejection Fraction

Circulation

It is primarily indicated for refractory angina that is not amenable to PCI or CABG with the opinion of a cardiologist. Despite being a heart transplantation candidate, she declined revascularization and sought alternative treatments for angina, dyspnea, and daily activity limitations.